This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

US FTC says it has shown Edwards-JenaValve deal likely creates monopoly

( December 16, 2025, 20:24 GMT | Official Statement) -- MLex Summary: The proposed transaction between Edwards Lifesciences and JenaValve is likely to lessen competition and tends to create a monopoly, the US Federal Trade Commission says it has proven. The agency's proposed findings of fact and conclusions of law highlights its argued market definition and that the companies took actions to try and avoid antitrust regulation.See attached document....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login